Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Capital Leases: 2009-2014

Historic Capital Leases for Madrigal Pharmaceuticals (MDGL) over the last 6 years, with Dec 2014 value amounting to $43,000.

  • Madrigal Pharmaceuticals' Capital Leases fell 79.63% to $11,000 in Q3 2015 from the same period last year, while for Sep 2015 it was $11,000, marking a year-over-year decrease of 79.63%. This contributed to the annual value of $43,000 for FY2014, which is 49.41% down from last year.
  • According to the latest figures from FY2014, Madrigal Pharmaceuticals' Capital Leases is $43,000, which was down 49.41% from $85,000 recorded in FY2013.
  • Madrigal Pharmaceuticals' 5-year Capital Leases high stood at $201,000 for FY2010, and its period low was $1,000 during FY2012.
  • In the last 3 years, Madrigal Pharmaceuticals' Capital Leases had a median value of $27,000 in 2012 and averaged $35,000.
  • Per our database at Business Quant, Madrigal Pharmaceuticals' Capital Leases crashed by 93.03% in 2011 and then skyrocketed by 8,400.00% in 2013.
  • Madrigal Pharmaceuticals' Capital Leases (Yearly) stood at $201,000 in 2010, then slumped by 93.03% to $14,000 in 2011, then reached $11,000 in 2012, then plummeted by 92.86% to $1,000 in 2012, then spiked by 8,400.00% to $85,000 in 2013, then plummeted by 49.41% to $43,000 in 2014.